Bridger Management »

Catalyst Pharmaceutical Partners shares owned by Bridger Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Bridger Management from 13F filings

Historical chart of Bridger Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Bridger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Bridger Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.9M 185k 15.49
2024-03-31 $2.9M 185k 15.94
2023-12-31 $3.1M 185k 16.81

More positions owned by Bridger Management

Eli Lilly & Co. (LLY)
Uber Technologies (UBER)
Vertex Pharmaceuticals Incorporated (VRTX)
Morgan Stanley Com New (MS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Pfizer (PFE)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alnylam Pharmaceuticals (ALNY)
Bath &#38 Body Works In (BBWI)
Bausch Plus Lomb Corp Common Shares (BLCO)
Melco Resorts And Entmnt Adr (MLCO)
Caesars Entertainment (CZR)
Xenon Pharmaceuticals (XENE)
Geron Corporation (GERN)
Springworks Therapeutics (SWTX)

View all positions for Bridger Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Henderson Group
Royce & Associates
Northern Trust
Kennedy Capital Management
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners